Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3419880 | Revue de Pneumologie Clinique | 2010 | 8 Pages |
Abstract
Based on FDG-PET, management was modified in 19/89 (21.3%) patients, but these changes were justified in only 9/89 patients (10.1%). FDG-PET can detect asymptomatic local and distant metastases and improves the preoperative assessment of NSCLC, thereby avoiding unnecessary surgery. However, histological verification is required because of the risk of false-positive results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
J. Margery, B. Milleron, F. Vaylet, D. Grahek, B. Lebeau, G. Mangiapan, G. Bonardel, C. de Labriolle-Vaylet, M. Meignan, M.-F. Carette, J.-N. Talbot, B. Housset,